Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Can FDG-PET/CT imaging be used to prognosticate in Interstitial Lung Disease? A prospective study of the relationship between FDG-PET/CT measurements and quality of life.

L Jordon, B Ganeshan, I Nadeem, L Hoy, N Mahdi, J Porter, A Groves, T Win, I Nadeem
European Respiratory Journal 2022 60: 2473; DOI: 10.1183/13993003.congress-2022.2473
L Jordon
1Cambridge University Hospitals, Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B Ganeshan
2University College London Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I Nadeem
3Luton & Dunstable Hospitals NHS Foundation Trust, Luton, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L Hoy
2University College London Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N Mahdi
3Luton & Dunstable Hospitals NHS Foundation Trust, Luton, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Porter
2University College London Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Groves
2University College London Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T Win
4Lister Hospital, Stevenage, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I Nadeem
5, BEDFORD, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 60 no. suppl 66
DOI 
https://doi.org/10.1183/13993003.congress-2022.2473

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online December 1, 2022.

Copyright & Usage 
Copyright ©the authors 2022

Author Information

  1. L Jordon1,
  2. B Ganeshan2,
  3. I Nadeem3,
  4. L Hoy2,
  5. N Mahdi3,
  6. J Porter2,
  7. A Groves2,
  8. T Win4 and
  9. I Nadeem5
  1. 1Cambridge University Hospitals, Cambridge, United Kingdom
  2. 2University College London Hospital, London, United Kingdom
  3. 3Luton & Dunstable Hospitals NHS Foundation Trust, Luton, United Kingdom
  4. 4Lister Hospital, Stevenage, United Kingdom
  5. 5, BEDFORD, United Kingdom

Article usage

Article usage: December 2022 to February 2023

AbstractFullPdf
Dec 20223300
Jan 20232400
Feb 20231500

Altmetrics

Previous
Back to top
Vol 60 Issue suppl 66 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Can FDG-PET/CT imaging be used to prognosticate in Interstitial Lung Disease? A prospective study of the relationship between FDG-PET/CT measurements and quality of life.
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Can FDG-PET/CT imaging be used to prognosticate in Interstitial Lung Disease? A prospective study of the relationship between FDG-PET/CT measurements and quality of life.
L Jordon, B Ganeshan, I Nadeem, L Hoy, N Mahdi, J Porter, A Groves, T Win, I Nadeem
European Respiratory Journal Sep 2022, 60 (suppl 66) 2473; DOI: 10.1183/13993003.congress-2022.2473

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Can FDG-PET/CT imaging be used to prognosticate in Interstitial Lung Disease? A prospective study of the relationship between FDG-PET/CT measurements and quality of life.
L Jordon, B Ganeshan, I Nadeem, L Hoy, N Mahdi, J Porter, A Groves, T Win, I Nadeem
European Respiratory Journal Sep 2022, 60 (suppl 66) 2473; DOI: 10.1183/13993003.congress-2022.2473
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Association between the Use of Statins and Incidence of Interstitial Lung Disease/Idiopathic Pulmonary Fibrosis: A Cohort Study
  • Blood neutrophil levels in IPF patients are significantly associated with quantitative radiological progression
  • Interim results from AIR, an open-label, single arm, 36-week ph 2 trial of C21 in subjects with idiopathic pulmonary fibrosis
Show more 12.01 - Idiopathic interstitial pneumonias

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society